FDA sets up Novel Excipient Review Pilot Program
Manufacturers can submit their novel excipients for FDA review under the voluntary Novel Excipient Review Pilot Program.
List view / Grid view
Manufacturers can submit their novel excipients for FDA review under the voluntary Novel Excipient Review Pilot Program.
This application notes offers method optimisation tips for purification, concentration and formulation of proteins and peptides.
In this article, European Pharmaceutical Review’s Hannah Balfour explores some of big pharma’s latest developments in HIV treatment, with commentary from ViiV Healthcare’s Head of Research and Development, Kimberly Smith.
This application note addresses the TOC limit changes in USP for packaged water. The new limits account for varying container volumes.
With 16 reactors at 1mL, The Crystal16 enables scientists to determine solubility curves, assess dispersion stability and critical solution temperatures.
Here, Dave Elder discusses the ever increasing importance of child-friendly medications and the specific challenges associated with their development.
It might be easy to dismiss non-life-threatening diseases of the skin or nail as trivial, but their impact on physical and mental wellbeing can be significant. Such diseases are obvious targets for topical treatments, but the lack of effective formulations means patients are often faced with the prospect of oral…
The COVID-19 pandemic spotlighted drug repurposing as a key strategy to support traditional novel chemical entity development; yet repurposing is just one example of how off-patent molecules can be further developed to provide patients with more treatment options. Here, Arun Narayan, Chairman of the Value Added Medicines Sector Group at…
Featured in this in-depth focus: why improving dosing accuracy with infusion pumps requires users to have a better understanding of the equipment and how nanomedicines could be instrumental in improving skin and nail diseases.
In our latest issue, features explore the use of nano formulations to improve skin and nail drug delivery, how to take cell and gene therapies from concept to commercialisation and what strategies you can use to overcome interfering factors in LAL bacterial endotoxin testing. Also in this journal, find out…
Grow X-ray quality crystals to make ensure you aren’t losing useful chemical information. Access diverse crystallisation methods with the CrystalBreeder!
13 August 2021 | By MasterControl
Watch our on-demand webinar to discover how MasterControl Manufacturing Excellence™ augments and enhances worker performance as part of digital transformation.
Automating your solid-state screening process enables you to perform the crystallisation experiments with just a small amount of effort.
In this whitepaper, C2C’s Product & Process Development Lead explains how using digital modelling in the design process can guarantee results.
Adare’s Optimµm® technology offers a unique and efficient method of fabricating monodisperse microparticles at reduced development time.